http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2034224-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c9446a65422eaca792040fe2b817fb5 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-553 |
| filingDate | 1991-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6504d89d16eae8da4909f504f165164d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fb57f5196e618c5dc239d23439744d2 |
| publicationDate | 1992-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2034224-A1 |
| titleOfInvention | 1-amino-5-halogenouracils, process for their preparation, and central nervous system depressants containing same as active ingredient |
| abstract | ABSTRACT OF THE DISCLOSURE Disclosed are a central nervous system depressant which comprises a 1-amino-5-halogenouracil represented by the formula [I] wherein X represents a halogen atom, or a pharmaceutically acceptable salt thereof as an active ingredient; a 1-amino-5-halogenouracil represented by the formula [II] wherein X' represents chlorine, bromine or iodine, or a salt thereof; and a process for preparing a 1-amino-5-halogenouracil represented by the above shown formula [I] from a pyrimidine derivative represented by the formula [III] wherein X represents a halogen atom and R represents a protective group. |
| priorityDate | 1991-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.